Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 18.58
+0.46 (2.54%)
Nov 7, 2025, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.35 billion as of November 7, 2025. Its market cap has increased by 45.81% in one year.
Market Cap
2.35B
Enterprise Value
2.05B
Revenue
218.86M
Ranking
n/a
PE Ratio
16.19
Stock Price
18.58
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.35B, an increase of 11,130.58%. That is a compound annual growth rate of 25.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 2.35B | 48.03% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | 147.27M | -40.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.53B |
| Pro Medicus | 26.40B |
| Cochlear | 18.63B |
| Sonic Healthcare | 10.33B |
| Ramsay Health Care | 7.09B |
| Ansell | 5.18B |
| Telix Pharmaceuticals | 5.08B |
| Mesoblast | 2.85B |